Clinically led, evidence based, AI powered

Our Company

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L) and is based in the Schrödinger Building, located on Oxford Science Park.

Professor Sir John Bell

Non-Executive Chairman

Professor Sir John Bell is Regius Professor of Medicine at the University of Oxford, and Chairman of the Office for the Strategic Coordination of Health Research. He served as President of the Academy of Medical Sciences from 2006 to 2011.

View Profile

Lord Drayson

Chief Executive Officer

Lord Drayson is an engineer and science entrepreneur who has over 25 years of experience in founding and leading successful businesses in food manufacturing, bioscience and motorsport research and development.

View Profile

Professor Lionel Tarassenko

Non-Executive Director & Director of R&D

Professor Tarassenko is a leading expert in the application of signal processing and machine learning to medical systems, with a strong track record in translation to clinical medicine. His work has had a major impact on the identification of deterioration in acute care and on the self-management of long-term conditions using mobile communications.

View Profile

Lorimer Headley

Chief Financial Officer

Lorimer Headley was awarded his Masters at Heriot-Watt University in 1999, following which he became a Chartered Accountant and spent 16 years with PricewaterhouseCoopers in Edinburgh, Aberdeen, London and the United States.

View Profile

Andrew Gilbert

Senior Independent Director

In addition to his role on the Board, Andrew Gilbert acts as the non-executive chairman of Wirepas Oy and as a director of Gildrew Limited. Prior to this, Andrew served as executive vice president of European Innovation Development of Qualcomm Europe, Inc., leading Qualcomm’s activity in wireless power including WiPowerTM handset charging technology and Halo Wireless Electric Vehicle Charging technology. He acted as the executive adviser to Qualcomm until 2013. He also served as a member of Qualcomm’s executive committee.

View Profile

Dr. Anna Lisa Jenkins

Independent Non-Executive Director

Anna Lisa has a degree in Medicine from St. Bartholomew’s Hospital, served as a medical officer in the British Navy and was a specialist registrar in Cardiovascular Medicine with UK NHS.

View Profile

Mary Hardy

Independent Non-Executive Director

Mary Hardy is a chartered accountant and former partner at Ernst & Young with 20 years’ experience as Director of Internal Audit for Diageo, Transport for London and the London Olympics.

View Profile

Dr. Vishal Gulati

Independent Non-Executive Director

Dr. Vishal Gulati is a venture capitalist specialising in companies that lie at the convergence of healthcare with the internet, data science, AI and engineering.

View Profile

Sir Bruce Keogh

Independent Non-Executive Director

Sir Bruce Keogh is the Chair of Birmingham Women’s and Children’s NHS Foundation Trust, which is one of the highest performing NHS Trusts in the NHS.

View Profile

Charles Swingland

Non-Executive Director

Charles Swingland joined PowderJect Pharmaceuticals Plc in 1996 as Senior Vice President of Corporate Services and General Counsel, after several years as a partner in a law firm in the City of London.

View Profile

Rt. Hon. Lord Drayson

PhD FIET FREng​
Chief Executive Officer

Lord Drayson is an engineer and science entrepreneur who has over 25 years of experience in founding and leading successful businesses in food manufacturing, bioscience and motorsport research and development.

View Profile

Dr. Steven Hamblin

PhD
Chief Technology Officer

Steven is the CTO at Sensyne Health, where he is responsible for building and supporting the company's digital health software products as well as leading technological strategy in the company's biomedical research and Clinical AI ventures.

View Profile

Lorimer Headley

MA (Hons) CA
Chief Financial Officer

Lorimer Headley was awarded his Masters at Heriot-Watt University in 1999, following which he became a Chartered Accountant and spent 16 years with PricewaterhouseCoopers in Edinburgh, Aberdeen, London and the United States.

View Profile

Dr Nick Scott-Ram

MA PhD MBE
VP Strategic and Commercial Development

Nick has over 25 years’ experience in commercial and business development in the life sciences sector, in particular in pharmaceuticals. He has an MA in Natural Sciences and a PhD in the Philosophy of Science from Cambridge University.

View Profile

Dr. Roberto Liddi

PhD MTOPRA
VP Quality and Regulatory

Dr Roberto Liddi is an experienced commercial leader with over 20 years experience in medical device manufacturing. He is skilled in U.S. Food and Drug Administration (FDA) regulations, Regulatory Strategy, Corrective and Preventive Action (CAPA), Quality Auditing, and CE marking.

View Profile

Matthew Walsh

MSc MIET
Programmes Director

Matthew joined the company in 2016 having spent the majority of his career in the Aerospace industry. His role as Programmes Director is to deliver the company's programmes in compliance with the relevant regulatory standards.

View Profile

Kate O'Rourke

Operations Director

Kate is Operations Director for Sensyne Health with responsibility for customer support, IT, training, HR, operations.

View Profile

Julian Bradwell

Head of Sales

Julian is Head of Sales and Business Development for Sensyne Health with responsibility to deliver revenue targets with health care providers and commercial partners in the UK and international markets.

View Profile

Laura Steward

Head of Marketing & Communications

Laura joined the company in September 2017 with 20+ years’ experience working in B2B tech marketing and communications for a variety of international, SME and start-up organisations, finding her niche in healthcare and biotech 15 years ago.

View Profile

Amy Glees

Product Manager

After studying History of Medicine at York, Amy, via a short stint as a museum curator, joined a fledgling new media agency and helped introduce various FTSE 250 companies to web technologies.

View Profile

Dr. Johanna Barlow

MBChB BMedSci MRCGP
Clinical AI Product Owner

Johanna qualified as a Doctor from the University of Birmingham and also gained a degree there in Public Health, before going on to complete foundation training in North London.

View Profile

Professor Lionel Tarassenko

University of Oxford - Chairman

Professor Tarassenko is a leading expert in the application of signal processing and machine learning to medical systems, with a strong track record in translation to clinical medicine. His work has had a major impact on the identification of deterioration in acute care and on the self-management of long-term conditions using mobile communications.

View Profile

Professor David Clifton

University of Oxford - AI Research Director

Professor Clifton is an Associate Professor in the Department of Engineering Science of the University of Oxford. He is also a Research Fellow of the Royal Academy of Engineering.

View Profile

Professor Peter Watkinson

University of Oxford – Chief Medical Officer

Professor Watkinson is Associate Professor of Intensive Care Medicine and joint clinical lead for the Critical Care Research Group based at the Kadoorie Centre for Critical Care Research & Education at the John Radcliffe Hospital, Oxford.

View Profile

Dr. Lucy Mackillop

University of Oxford

Dr. Mackillop is a consultant obstetric physician at Oxford University Hospitals NHS Foundation Trust and Honorary Senior Clinical Lecturer, Nuffield Department of Women’s and Reproductive Health, University of Oxford.

View Profile

Dr. Lloyd B Minor

Stanford University

Dr. Minor is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since 1 December 2012. He is also a professor of Otolaryngology – Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.

View Profile

Professor Mike Bewick

National Health Service

Professor Mike Bewick is an experienced national clinical leader with over 35 years of NHS service, having worked in both acute and primary care.

View Profile

Schrödinger Building, Oxford Science Park

Oxford Office

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

+44 (0) 330 058 1845

Send us a message

For press enquiries, please contact press@sensynehealth.com

Get in touch

Thank you! Your submission has been received!
Back to website
Oops! Something went wrong while submitting the form.